Effects of lutein and docosahexaenoic Acid supplementation on macular pigment optical density in a randomized controlled trial
Keywords: 
Lutein
Docosahexaenoic acid
Age-related macular degeneration
Macular pigment density
Issue Date: 
2013
Publisher: 
MDPI
ISSN: 
2072-6643
Citation: 
García-Layana A, Recalde S, Alamán AS, Robredo PF. Effects of lutein and docosahexaenoic Acid supplementation on macular pigment optical density in a randomized controlled trial. Nutrients. 2013 Feb 15;5(2):543-51.
Abstract
We studied the macular pigment ocular density (MPOD) in patients with early age macular degeneration (AMD) before and 1 year after nutritional supplementation with lutein and docosahexaenoic acid (DHA). Forty-four patients with AMD were randomly divided into two groups that received placebo (n = 21) or a nutritional supplement (n = 23, 12 mg of lutein and 280 mg of DHA daily). Heterochromatic flicker photometry was used to determine the MPOD. At baseline, the MPOD in AMD patients with placebo was 0.286 ± 0.017 meanwhile in AMD patients with supplementation it was 0.291 ± 0.016. One year later, the mean MPOD had increased by 0.059 in the placebo group and by 0.162 in patients receiving lutein and DHA. This difference between groups was significant (p < 0.05). Lutein and DHA supplementation is effective in increasing the MPOD and may aid in prevention of age related macular degeneration.

Files in This Item:
File: 
nutrients- 2013 05-00543.pdf
Description: 
Size: 
698,31 kB
Format: 
Adobe PDF


Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.